Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Open forum infectious diseases [Open Forum Infect Dis] NLMUID: 101637045"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 4074
Tytuł:
Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings-A French Real-world Study.
Autorzy:
Timsit JF; Réanimation Médicale et Infectieuse, AP-HP Bichat, Paris, France.
Mootien J; Unité Fonctionnelle de Conseil en Antibiothérapie, CHU Mulhouse, Mulhouse, France.
Akrich B; MSD France, Puteaux, France.
Bourge X; MSD France, Puteaux, France.
Brassac I; MSD France, Puteaux, France.
Castan B; Service de Médecine Interne et Maladies Infectieuses, CH Périgueux, Périgueux, France.
Mackosso C; MSD France, Puteaux, France.
Tavares LM; ClinSearch, Malakoff, France.
Ruiz F; ClinSearch, Malakoff, France.
Boutoille D; Service des Maladies Infectieuses, Nantes Université, CIC 1413, Inserm, Nantes, France.
Ruimy R; Laboratoire Médicale, CHU Nice, Nice.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 22; Vol. 11 (2), pp. ofae037. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction to: 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022.
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 20; Vol. 11 (2), pp. ofae100. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction to: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 19; Vol. 11 (2), pp. ofad602. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hypoxemic Respiratory Failure and Coccidioidomycosis-Associated Acute Respiratory Distress Syndrome.
Autorzy:
Heidari A; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Bakersfield, California, USA.; Dignity Health, Bakersfield Memorial Hospital, Bakersfield, California, USA.; Valley Fever Institute, Bakersfield, California, USA.
Kaur S; Valley Fever Institute, Bakersfield, California, USA.; Division of Infectious Diseases, Department of Internal Medicine, Kern Medical, Bakersfield, California, USA.
Pearson SJ; University of California-Davis Medical Center, Sacramento, CA, USA.
Munoz A; Valley Fever Institute, Bakersfield, California, USA.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kern Medical, Bakersfield, California, USA.
Sandhu H; Division of Infectious Diseases, Department of Internal Medicine, Kern Medical, Bakersfield, California, USA.
Mann G; University of California-Davis Medical Center, Sacramento, CA, USA.
Schivo M; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center, Sacramento, CA, USA.
Zeki AA; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center, Sacramento, CA, USA.
Bays DJ; Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA, USA.
Wilson M; Department of Public Health Sciences, University of California- Davis, Davis, California, USA.
Albertson TE; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center, Sacramento, CA, USA.
Johnson R; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Bakersfield, California, USA.; Valley Fever Institute, Bakersfield, California, USA.; Division of Infectious Diseases, Department of Internal Medicine, Kern Medical, Bakersfield, California, USA.
Thompson GR; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, UC Davis Lung Center, University of California Davis Medical Center, Sacramento, CA, USA.; Department of Medical Microbiology and Immunology, University of California-Davis Medical Center, Davis, California, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 14; Vol. 11 (2), pp. ofad679. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Typ publikacji:
Clinical Trial
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes.
Autorzy:
Matsuo T; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wurster S; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tarrand J; Section of Clinical Microbiology and Virology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 13; Vol. 11 (2), pp. ofae068. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort.
Autorzy:
Decker S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Xiao S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dillen C; Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Schumacher CM; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Milstone AM; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Frieman M; Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Debes AK; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 13; Vol. 11 (2), pp. ofad625. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal Analysis of Mpox Virus DNA Detectability From Multiple Specimen Types During Acute Illness: A Cohort Study.
Autorzy:
Tan DHS; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Pico Espinosa O; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
Matelski J; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.
Khera SS; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
Qamar A; Scarborough Health Network, Scarborough, Ontario, Canada.
Persaud R; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
Hurst JR; Biological Sciences, Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Ontario, Canada.
Ly A; Toronto High Containment Facility, Temerty Medicine, University of Toronto, Toronto, Ontario, Canada.
Lam J; Toronto High Containment Facility, Temerty Medicine, University of Toronto, Toronto, Ontario, Canada.
Naghibosadat M; Biological Sciences, Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Ontario, Canada.
Christie N; Toronto High Containment Facility, Temerty Medicine, University of Toronto, Toronto, Ontario, Canada.
Hasso M; Public Health Ontario Laboratory, Toronto, Ontario, Canada.
Gough K; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Taggart LR; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Tan C; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Ostrowski M; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Ma H; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
Gray-Owen SD; Toronto High Containment Facility, Temerty Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Molecular Genetics, Temerty Medicine, University of Toronto, Toronto, Ontario, Canada.
Kozak R; Biological Sciences, Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Mishra S; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 07; Vol. 11 (2), pp. ofae073. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in Body Mass Index Over Time in People With and Without HIV Infection.
Autorzy:
Lam JO; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Leyden WA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Alexeeff S; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Lea AN; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Hechter RC; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Hu H; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Marcus JL; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pitts L; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Yuan Q; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Towner WJ; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Horberg MA; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 06; Vol. 11 (2), pp. ofad611. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Epidemiologic and Clinical Characteristics of the 2023 Dengue Outbreak in Bangladesh.
Autorzy:
Sharif N; Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Sharif N; Department of Mathematics, Rajshahi University of Engineering & Technology, Rajshahi, Bangladesh.
Khan A; Department of Statistics, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Dey SK; Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 02; Vol. 11 (2), pp. ofae066. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Epidemiology, Clinical Characteristics, and Diagnostic Testing Practices for Pneumocystis Pneumonia-Associated Hospitalizations, United States, 2019-2022.
Autorzy:
Benedict K; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Baggs J; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gold JAW; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 31; Vol. 11 (2), pp. ofae054. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intra-amniotic Candida albicans Infection Treated With Liposomal Amphotericin B With a Successful Neonatal Outcome.
Autorzy:
Gutiérrez NU; Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Vergara López MJ; Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Bustos CÁ; Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Vidal CC; Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Carvajal JA; Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Severino N; Programa de Farmacología y Toxicología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Medicina Intensiva, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Giordano A; Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Baquedano SU; Departamento de Neonatología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Feuerhake T; Departamento de Anatomía Patológica, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Rabagliati R; Departamento de Enfermedades Infecciosas del Adulto, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Balcells ME; Departamento de Enfermedades Infecciosas del Adulto, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 31; Vol. 11 (2), pp. ofae047. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Curriculum and Competency Guidelines for the Advanced Care Practitioner in Infectious Disease.
Autorzy:
Smith MA; Daytonand Karen Brown Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NewYork, USA.
Zelenetz P; Daytonand Karen Brown Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NewYork, USA.
Kim A; Daytonand Karen Brown Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NewYork, USA.
Donaghy H; Daytonand Karen Brown Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NewYork, USA.
Gould JS; Hofstra/Northwell School of Nursing and Physician Assistant Studies, 160 Hofstra University, Hempstead, NewYork, USA.
McLeod-Sordjan R; Hofstra/Northwell School of Nursing and Physician Assistant Studies, 160 Hofstra University, Hempstead, NewYork, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 31; Vol. 11 (1), pp. ofad589. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Knowledge and Attitudes on Contraception and Reproductive Health in Women With HIV.
Autorzy:
Henricks A; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Singal S; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Hughes D; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kelly S; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Castilho JL; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Norwood J; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 29; Vol. 11 (2), pp. ofae044. Date of Electronic Publication: 2024 Jan 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults.
Autorzy:
Maier HE; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Kowalski-Dobson T; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Eckard A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Gherasim C; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Manthei D; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Meyers A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Davis D; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Bakker K; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Lindsey K; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Chu Z; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Warsinske L; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Arnold M; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Buswinka A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Stoneman E; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Valdez R; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Gordon A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 23; Vol. 11 (2), pp. ofae039. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy.
Autorzy:
Alahmdi B; Division of Infectious Diseases, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Kaur A; Division of Infectious Diseases, Department of Medicine, City of Hope, Duarte, California, USA.
Jacobs SE; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Sullivan T; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Barghash M; Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Taimur S; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 23; Vol. 11 (1), pp. ofad698. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.
Autorzy:
Ciccone EJ; Division of Infectious Diseases, School of Medicine.
Zhu DR; Department of Epidemiology, Gillings School of Global Public Health.
Gunderson AK; Department of Epidemiology, Gillings School of Global Public Health.
Hawke S; Department of Biostatistics, Gillings School of Global Public Health.
Ajeen R; Institute for Global Health and Infectious Diseases.
Lodge EK; Department of Epidemiology, Gillings School of Global Public Health.
Shook-Sa BE; Department of Biostatistics, Gillings School of Global Public Health.
Abernathy H; Institute for Global Health and Infectious Diseases.
Garrett HE; Department of Epidemiology, Gillings School of Global Public Health.
King E; Institute for Global Health and Infectious Diseases.
Alavian N; Division of Hospital Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Reyes R; Division of Hospital Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Taylor JL; Institute for Global Health and Infectious Diseases.
Beatty C; Department of Epidemiology and Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, New York.
Chung C; Institute for Global Health and Infectious Diseases.
Mendoza CE; Department of Epidemiology, Gillings School of Global Public Health.
Weber DJ; Division of Infectious Diseases, School of Medicine.; Department of Epidemiology, Gillings School of Global Public Health.
Markmann AJ; Division of Infectious Diseases, School of Medicine.
Premkumar L; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Juliano JJ; Division of Infectious Diseases, School of Medicine.; Department of Epidemiology, Gillings School of Global Public Health.
Boyce RM; Division of Infectious Diseases, School of Medicine.; Department of Epidemiology, Gillings School of Global Public Health.
Aiello AE; Department of Epidemiology and Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, New York.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 19; Vol. 11 (1), pp. ofae009. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic Accuracy of Computer-Aided Detection During Active Case Finding for Pulmonary Tuberculosis in Africa: A Systematic Review and Meta-analysis.
Autorzy:
Scott AJ; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Perumal T; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Hohlfeld A; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Oelofse S; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Kühn L; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Swanepoel J; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Geric C; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Ahmad Khan F; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Esmail A; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Ochodo E; Kenya Medical Research Institute, Nairobi, Kenya.; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Engel M; Department of Medicine, University of Cape Town, Cape Town, South Africa.; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Dheda K; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 17; Vol. 11 (2), pp. ofae020. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stem Cell Transplant in Immune-deficiency-associated Vaccine-derived Poliovirus.
Autorzy:
Ranchod H; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Howard W; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Roux A; Dr Adéle Roux Practice, Life Groenkloof Hospital, Pretoria, South Africa.
van Zyl W; Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, National Health Laboratory Services-Tshwane Academic Division, Pretoria, South Africa.
Ekermans P; Department of Medical Microbiology, Ampath Laboratories, Pretoria, South Africa.
van den Berg S; Department of Immunology, Ampath Laboratories, Pretoria, South Africa.
Seakamela L; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Makua K; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Yousif M; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sibiya R; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Du Plessis H; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Phalane E; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
McCarthy K; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Moonsamy S; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Reynders D; Department of Paediatrics, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Hincks J; ViroDefense, Chevy Chase, Maryland, USA.
Suchard MS; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
du Plessis NM; Department of Paediatrics, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 17; Vol. 11 (2), pp. ofad678. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 4074

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies